# Indaptus Therapeutics, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:c90ec6d7-75b6-423f-a873-18a064abae4e |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/indaptus-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 21 |
| Claims under review | 1 |
| Evidence records | 8 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-15T04:46:27.244532+00:00 |
| Last reviewed | 2026-10-15T04:46:27.244532+00:00 |

## Identity

- Legal name: Indaptus Therapeutics, Inc.
- Display name: Indaptus Therapeutics, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-15T23:35:45.523793+00:00 |
| Completeness | 0.364 |
| Record Quality | 0.836 |
| Directors | 11 |
| Committees | 0 |
| Governance events | 10 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | NOT_REVIEWED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Avraham Ben-Tzvi: Director. Status: current. Independent: false. Since: 2025-01-01. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:6
- David E. Lazar: Director. Status: current. Independent: false. Since: 2025-01-01. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:7
- David Natan: Director. Status: current. Independent: false. Since: 2026-01-01. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:8
- Mark J. Gilbert: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:11
- Anthony J. Maddaluna: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:5
- Jeffrey A. Meckler: Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:9
- Jerome D. Jabbour: Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:10
- Matthew McMurdo: Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:12
- Michael J. Newman: Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:13
- Roger J. Pomerantz: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:14
- William B. Hayes: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:15

## Executive leadership

- David E. Lazar: Co-Chief Executive Officer and Chairman [CEO]. Status: current. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:16
- Jeffrey A. Meckler: Co-Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:17
- Matthew McMurdo: Vice President, New Strategies. Status: current. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:18
- Michael J. Newman, Ph.D.: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:19
- Nir Sassi: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:20
- Walt A. Linscott, Esq.: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:21

## Governance events

- CEO_CHANGED: David E. Lazar executive of Indaptus Therapeutics, Inc., effective 2026-03-17. Effective: 2026-03-17. Detected: 2026-10-15T04:46:27.244532+00:00. event_id=alpha:event:transition:1km90796rjfsx
- CEO_CHANGED: Jeffrey A. Meckler executive of Indaptus Therapeutics, Inc., effective 2026-03-17. Effective: 2026-03-17. Detected: 2026-10-15T04:46:27.244532+00:00. event_id=alpha:event:transition:1srylao1ip95ws
- EXECUTIVE_APPOINTED: Matthew McMurdo executive of Indaptus Therapeutics, Inc., effective 2026-03-17. Effective: 2026-03-17. Detected: 2026-10-15T04:46:27.244532+00:00. event_id=alpha:event:transition:1b9tcfr2w1ygf
- EXECUTIVE_APPOINTED: Michael J. Newman, Ph.D. executive of Indaptus Therapeutics, Inc., effective 2026-03-17. Effective: 2026-03-17. Detected: 2026-10-15T04:46:27.244532+00:00. event_id=alpha:event:transition:13hfell1kl09l5
- CFO_CHANGED: Nir Sassi executive of Indaptus Therapeutics, Inc., effective 2026-03-17. Effective: 2026-03-17. Detected: 2026-10-15T04:46:27.244532+00:00. event_id=alpha:event:transition:8mfuhd546jtf
- EXECUTIVE_APPOINTED: Walt A. Linscott, Esq. executive of Indaptus Therapeutics, Inc., effective 2026-03-17. Effective: 2026-03-17. Detected: 2026-10-15T04:46:27.244532+00:00. event_id=alpha:event:transition:byltel1vd7x2h
- DIRECTOR_APPOINTED: David Natan seat on Indaptus Therapeutics, Inc., effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-10-15T04:46:27.244532+00:00. event_id=alpha:event:transition:13vibu0qopk8y
- DIRECTOR_APPOINTED: Avraham Ben-Tzvi seat on Indaptus Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-15T04:46:27.244532+00:00. event_id=alpha:event:transition:1rtay7r11vjmdf
- DIRECTOR_APPOINTED: David E. Lazar seat on Indaptus Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-15T04:46:27.244532+00:00. event_id=alpha:event:transition:1vchrsuq9t4ze
- DIRECTOR_APPOINTED: Mark J. Gilbert seat on Indaptus Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-15T04:46:27.244532+00:00. event_id=alpha:event:transition:oq1s6tlktftt

## Scoped resources

- `alpha://company/indaptus-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record
- `alpha://company/indaptus-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=identity
- `alpha://company/indaptus-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=corporate-structure
- `alpha://company/indaptus-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=board
- `alpha://company/indaptus-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=committees
- `alpha://company/indaptus-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=leadership
- `alpha://company/indaptus-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=ownership
- `alpha://company/indaptus-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=financials
- `alpha://company/indaptus-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=capital-structure
- `alpha://company/indaptus-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=compensation
- `alpha://company/indaptus-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=governance
- `alpha://company/indaptus-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=shareholder-governance
- `alpha://company/indaptus-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=audit
- `alpha://company/indaptus-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=legal
- `alpha://company/indaptus-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=risk
- `alpha://company/indaptus-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=cyber
- `alpha://company/indaptus-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=ai-governance
- `alpha://company/indaptus-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=agents
- `alpha://company/indaptus-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=ecosystem
- `alpha://company/indaptus-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=events
- `alpha://company/indaptus-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=relationships
- `alpha://company/indaptus-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=assessments
- `alpha://company/indaptus-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Anthony J. Maddaluna: Director. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b51d9484f2e40b756706729d79e8ac67dd11eba7e35c0f5d86ba38e94d5743aa.
- Avraham Ben-Tzvi: Director. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:6. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b51d9484f2e40b756706729d79e8ac67dd11eba7e35c0f5d86ba38e94d5743aa.
- David E. Lazar: Director. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:7. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b51d9484f2e40b756706729d79e8ac67dd11eba7e35c0f5d86ba38e94d5743aa.
- David Natan: Director. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:8. Valid from: 2026-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b51d9484f2e40b756706729d79e8ac67dd11eba7e35c0f5d86ba38e94d5743aa.
- Jeffrey A. Meckler: Director. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b51d9484f2e40b756706729d79e8ac67dd11eba7e35c0f5d86ba38e94d5743aa.
- Jerome D. Jabbour: Director. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b51d9484f2e40b756706729d79e8ac67dd11eba7e35c0f5d86ba38e94d5743aa.
- Mark J. Gilbert: Director. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:11. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b51d9484f2e40b756706729d79e8ac67dd11eba7e35c0f5d86ba38e94d5743aa.
- Matthew McMurdo: Director. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b51d9484f2e40b756706729d79e8ac67dd11eba7e35c0f5d86ba38e94d5743aa.
- Michael J. Newman: Director. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b51d9484f2e40b756706729d79e8ac67dd11eba7e35c0f5d86ba38e94d5743aa.
- Roger J. Pomerantz: Director. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b51d9484f2e40b756706729d79e8ac67dd11eba7e35c0f5d86ba38e94d5743aa.
- William B. Hayes: Director. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b51d9484f2e40b756706729d79e8ac67dd11eba7e35c0f5d86ba38e94d5743aa.
- David E. Lazar: Co-Chief Executive Officer and Chairman. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:16. Valid from: 2026-03-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:768e2d241961df907caba6a95a496e75321403e3465ae7e7b9a2978f23ad483a.
- Jeffrey A. Meckler: Co-Chief Executive Officer and Director. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:17. Valid from: 2026-03-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5163efedc59280c632b1cbc10026c126e42ee6bf76fcb4591273bd8a0a5a6508.
- Matthew McMurdo: Vice President, New Strategies. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:18. Valid from: 2026-03-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8cd8352c5547a6392982b9e1dd02a65fa72a5ac52364555cae276b828b60acc3.
- Michael J. Newman, Ph.D.: Chief Scientific Officer. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:19. Valid from: 2026-03-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e04e6e5b26a87285c475c62cb16ae0240c4f2d5718d240027d75a9eb8e452775.
- Nir Sassi: Chief Financial Officer. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:20. Valid from: 2026-03-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4694357e901c23f4c22bf916232121c1f83a054d89934962d149dcda4d8b71b8.
- Walt A. Linscott, Esq.: Chief Operating Officer. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:leadership_role:21. Valid from: 2026-03-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7cbed8eb080a8d819a07d0f5c7c3ceabfcd52364751730c80609c6ad587896f3.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- PUBLISHED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Indaptus Therapeutics, Inc.. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7550955b8aea70daf8840764dc1285d0172ff0da28aa29108e0ac98a50b5672a.

## Entity Status

- Public listing published. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7550955b8aea70daf8840764dc1285d0172ff0da28aa29108e0ac98a50b5672a.

## Published Fact

- US. Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7550955b8aea70daf8840764dc1285d0172ff0da28aa29108e0ac98a50b5672a.

## Security Listing

- INDP (NASDAQ). Claim: alpha:claim:company:c90ec6d7-75b6-423f-a873-18a064abae4e:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7550955b8aea70daf8840764dc1285d0172ff0da28aa29108e0ac98a50b5672a.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:7550955b8aea70daf8840764dc1285d0172ff0da28aa29108e0ac98a50b5672a: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/indaptus-therapeutics-inc).
- alpha:projection-evidence:document:b51d9484f2e40b756706729d79e8ac67dd11eba7e35c0f5d86ba38e94d5743aa: [Indaptus Therapeutics, Inc. DEF 14A 2026-01-21](https://www.sec.gov/Archives/edgar/data/1857044/000149315226003135/formdef14a.htm).
- alpha:projection-evidence:document:768e2d241961df907caba6a95a496e75321403e3465ae7e7b9a2978f23ad483a: [INDP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1857044/000149315226010585/form10-k.htm).
- alpha:projection-evidence:document:5163efedc59280c632b1cbc10026c126e42ee6bf76fcb4591273bd8a0a5a6508: [INDP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1857044/000149315226010585/form10-k.htm).
- alpha:projection-evidence:document:8cd8352c5547a6392982b9e1dd02a65fa72a5ac52364555cae276b828b60acc3: [INDP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1857044/000149315226010585/form10-k.htm).
- alpha:projection-evidence:document:e04e6e5b26a87285c475c62cb16ae0240c4f2d5718d240027d75a9eb8e452775: [INDP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1857044/000149315226010585/form10-k.htm).
- alpha:projection-evidence:document:4694357e901c23f4c22bf916232121c1f83a054d89934962d149dcda4d8b71b8: [INDP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1857044/000149315226010585/form10-k.htm).
- alpha:projection-evidence:document:7cbed8eb080a8d819a07d0f5c7c3ceabfcd52364751730c80609c6ad587896f3: [INDP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1857044/000149315226010585/form10-k.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/indaptus-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/indaptus-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/indaptus-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/indaptus-therapeutics-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-15T23:35:45.320036+00:00; recorded 2026-10-15T23:35:45.320036+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.